Cargando…

The role of ADAMTS‐13 and von Willebrand factor in cancer patients: Results from the Vienna Cancer and Thrombosis Study

ESSENTIALS: Cancer is associated with increased risk of developing venous thrombosis. Cancer patients were studied for ADAMTS‐13 and VWF levels and occurrence of venous thrombosis. Increased VWF in cancer patients is associated with a higher risk of venous thrombosis. Low levels of ADAMTS‐13 and/or...

Descripción completa

Detalles Bibliográficos
Autores principales:	Obermeier, Hanna L., Riedl, Julia, Ay, Cihan, Koder, Silvia, Quehenberger, Peter, Bartsch, Rupert, Kaider, Alexandra, Zielinski, Christoph C., Pabinger, Ingrid
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Online‐only Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6611368/ https://www.ncbi.nlm.nih.gov/pubmed/31294335 http://dx.doi.org/10.1002/rth2.12197

Ejemplares similares

The Intriguing Connections between von Willebrand Factor, ADAMTS13 and Cancer
por: Colonne, Chanukya K., et al.
Publicado: (2022)

ADAMTS‐13 and bleeding phenotype in von Willebrand disease
por: Boender, Johan, et al.
Publicado: (2020)

The von Willebrand factor – ADAMTS‐13 axis in malaria
por: O’Donnell, Andrew S., et al.
Publicado: (2022)

Gemcitabine and Platinum-Based Agents for the Prediction of Cancer-Associated Venous Thromboembolism: Results from the Vienna Cancer and Thrombosis Study
por: Moik, Florian, et al.
Publicado: (2020)

Influence of blood group, von Willebrand factor levels, and age on factor VIII levels in non‐severe haemophilia A
por: Rejtő, Judit, et al.
Publicado: (2020)

ADAMTS‐13 and von Willebrand factor: a dynamic duo
por: South, K., et al.
Publicado: (2017)

Von Willebrand factor, ADAMTS13 and mortality in dialysis patients
por: Ocak, Gurbey, et al.
Publicado: (2021)

The VWF binding aptamer rondoraptivon pegol increases platelet counts and VWF/FVIII in type 2B von Willebrand disease
por: Ay, Cihan, et al.
Publicado: (2022)

Antithrombin Activity and Association with Risk of Thrombosis and Mortality in Patients with Cancer
por: Englisch, Cornelia, et al.
Publicado: (2022)

The von Willebrand factor–binding aptamer rondaptivon pegol as a treatment for severe and nonsevere hemophilia A
por: Ay, Cihan, et al.
Publicado: (2023)

PB2650: ALLOANTIBODIES IN VON WILLEBRAND DISEASE: ABOUT 6 CASES IN SOUTHERN TUNISIA
por: Chalbaoui, Amal, et al.
Publicado: (2023)

Proteolytic Processing of Von Willebrand Factor by Adamts13 and Leukocyte Proteases
por: Lancellotti, Stefano, et al.
Publicado: (2013)

Biological variations of ADAMTS13 and von Willebrand factor in human adults
por: Kilercik, Meltem, et al.
Publicado: (2014)

Increased Von Willebrand factor, decreased ADAMTS13 and thrombocytopenia in melioidosis
por: Birnie, Emma, et al.
Publicado: (2017)

The Intriguing Relationships of von Willebrand Factor, ADAMTS13 and Cardiac Disease
por: Reardon, Benjamin, et al.
Publicado: (2021)

How I treat cancer-associated thrombosis
por: Moik, Florian, et al.
Publicado: (2020)

A new measure for in vivo thrombin activity in comparison with in vitro thrombin generation potential in patients with hyper- and hypocoagulability
por: Königsbrügge, Oliver, et al.
Publicado: (2016)

Characterization of Conformation-Sensitive Antibodies to ADAMTS13, the von Willebrand Cleavage Protease
por: Sauna, Zuben E., et al.
Publicado: (2009)

Correction: Increased Von Willebrand factor, decreased ADAMTS13 and thrombocytopenia in melioidosis
por: Birnie, Emma, et al.
Publicado: (2020)

Von Willebrand Factor and ADAMTS-13 Are Associated with the Severity of COVID-19 Disease
por: Dolgushina, Nataliya, et al.
Publicado: (2022)

Porcine and Canine von Willebrand Factor and von Willebrand Disease: Hemostasis, Thrombosis, and Atherosclerosis Studies
por: Nichols, Timothy C., et al.
Publicado: (2010)

The Plasma Levels of ADAMTS-13, von Willebrand Factor, VWFpp, and Fibrin-Related Markers in Patients With Systemic Sclerosis Having Thrombosis
por: Habe, Koji, et al.
Publicado: (2017)

Cardiovascular risk factors are major determinants of thrombotic risk in patients with the lupus anticoagulant
por: Posch, Florian, et al.
Publicado: (2017)

Lupus anticoagulant test persistence over time and its associations with future thrombotic events
por: Colling, Meaghan E., et al.
Publicado: (2022)

PB2239: ACQUIRED VON WILLEBRAND DISEASE (AVWD) DIAGNOSTIC PROFILE IN MYELOPROLIFERATIVE NEOPLASIA (MN) PATIENTS IN WESTERN-ESTONIA
por: Vaide, Ines, et al.
Publicado: (2023)

Direct oral anticoagulants compared to low‐molecular‐weight heparin for the treatment of cancer‐associated thrombosis: Updated systematic review and meta‐analysis of randomized controlled trials
por: Moik, Florian, et al.
Publicado: (2020)

Low extracellular vesicle–associated tissue factor activity in patients with persistent lupus anticoagulant and a history of thrombosis
por: Hell, Lena, et al.
Publicado: (2018)

BMI is an important determinant of VWF and FVIII levels and bleeding phenotype in patients with von Willebrand disease
por: Atiq, Ferdows, et al.
Publicado: (2019)

von Willebrand Factor, Free Hemoglobin and Thrombosis in ECMO
por: Valladolid, Christian, et al.
Publicado: (2018)

Severe Dengue Is Associated with Consumption of von Willebrand Factor and Its Cleaving Enzyme ADAMTS-13
por: Djamiatun, Kis, et al.
Publicado: (2012)

Plasmatic ADAMTS-13 metalloprotease and von Willebrand factor in children with cyanotic congenital heart disease
por: Soares, R.P.S., et al.
Publicado: (2013)

A model for the conformational activation of the structurally quiescent metalloprotease ADAMTS13 by von willebrand factor
por: South, Kieron, et al.
Publicado: (2017)

Histone-induced thrombotic thrombocytopenic purpura in adamts13(−/−) zebrafish depends on von Willebrand factor
por: Zheng, Liang, et al.
Publicado: (2020)

Insights Into Immunothrombosis: The Interplay Among Neutrophil Extracellular Trap, von Willebrand Factor, and ADAMTS13
por: Yang, Junxian, et al.
Publicado: (2020)

Characterization of ADAMTS13 and von Willebrand factor levels in septic and non-septic ICU patients
por: Singh, Kanwal, et al.
Publicado: (2021)

Quantification of von Willebrand factor and ADAMTS-13 after traumatic injury: a pilot study
por: MacArthur, Taleen A, et al.
Publicado: (2021)

Von Willebrand factor and ADAMTS13 activity as clinical severity markers in patients with COVID-19
por: Marco, A, et al.
Publicado: (2021)

Von Willebrand Factor and ADAMTS13 as Predictors of Adverse Outcomes in Patients With Nonvalvular Atrial Fibrillation
por: Wysokinski, Waldemar E., et al.
Publicado: (2020)

Plasma ADAMTS13 and von Willebrand factor in diagnosis and prediction of prognosis in pulmonary arterial hypertension
por: Ahmed, Abdulla, et al.
Publicado: (2021)

Secretion of von Willebrand Factor and Suppression of ADAMTS-13 Activity by Markedly High Concentration of Ferritin
por: Bashir, Dalia A., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_41mpqu3cji13kao6lfdsm9hk1d